Display options
Share it on

Front Immunol. 2021 Sep 10;12:713351. doi: 10.3389/fimmu.2021.713351. eCollection 2021.

Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24.

Frontiers in immunology

Nina Körber, Laureen Pohl, Birgit Weinberger, Beatrix Grubeck-Loebenstein, Andrea Wawer, Percy A Knolle, Hedwig Roggendorf, Ulrike Protzer, Tanja Bauer

Affiliations

  1. Institute of Virology, Helmholtz Zentrum München, Munich, Germany.
  2. German Center for Infection Research (DZIF), Munich, Germany.
  3. Institute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.
  4. Occupational Health Unit, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
  5. Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
  6. Institute of Virology, School of Medicine, Technical University of Munich (TUM), Munich, Germany.

PMID: 34566969 PMCID: PMC8461011 DOI: 10.3389/fimmu.2021.713351

Abstract

BACKGROUND: The cellular mechanisms involved in the lack of protective antibody response after hepatitis B vaccination are still rather unclear. Regulatory B cells (Breg) known as modulators of B-and T-cell responses may contribute to poor vaccine responsiveness. The current study aimed to investigate the role of regulatory B cells (Breg) in hepatitis B vaccine non-responsiveness after immunization with second- or third-generation hepatitis B vaccines.

METHOD: We performed comparative phenotypic and frequency analysis of Breg subsets (CD24

RESULTS: Flow cytometry-based analyses revealed elevated frequencies of CD24

CONCLUSION: Here we report significantly higher frequencies of CD24

Copyright © 2021 Körber, Pohl, Weinberger, Grubeck-Loebenstein, Wawer, Knolle, Roggendorf, Protzer and Bauer.

Keywords: B10+ cells; IL-10 expression; hepatitis B vaccination; regulatory B cells; vaccine non-responsiveness

Conflict of interest statement

UP received funding for the project from the Helmholtz Association in context of the iMed initiative and the Helmholtz-Alberta-Initiative in Infectious Disease Research. UP serves as scientific adviso

References

  1. Lancet. 2002 Sep 28;360(9338):991-5 - PubMed
  2. Vaccine. 2006 Jun 29;24(26):5509-15 - PubMed
  3. Immunol Today. 1996 Mar;17(3):138-46 - PubMed
  4. Immunity. 2015 Apr 21;42(4):607-12 - PubMed
  5. J Med Virol. 2006 Feb;78(2):169-77 - PubMed
  6. Hepatology. 2005 Jul;42(1):72-6 - PubMed
  7. J Clin Virol. 2003 Aug;27(3):213-30 - PubMed
  8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1565-76 - PubMed
  9. PLoS One. 2013 Dec 11;8(12):e82779 - PubMed
  10. Arch Virol. 2019 Nov;164(11):2645-2658 - PubMed
  11. Med Microbiol Immunol. 2015 Feb;204(1):57-68 - PubMed
  12. Vaccine. 2014 Sep 3;32(39):5077-82 - PubMed
  13. Hepatology. 2001 Oct;34(4 Pt 1):798-802 - PubMed
  14. Eur J Immunol. 2014 Jun;44(6):1615-21 - PubMed
  15. Tissue Antigens. 1997 Jul;50(1):8-14 - PubMed
  16. Scand J Immunol. 2002 Mar;55(3):311-4 - PubMed
  17. Vaccine. 2006 Apr 5;24(15):2781-9 - PubMed
  18. Hepatology. 2000 Feb;31(2):521-7 - PubMed
  19. Clin Exp Immunol. 1996 Jul;105(1):52-8 - PubMed
  20. Vaccine. 2010 Sep 7;28(39):6411-6 - PubMed
  21. Curr Opin Immunol. 2014 Jun;28:77-83 - PubMed
  22. Pathol Biol (Paris). 2010 Aug;58(4):258-66 - PubMed
  23. Blood. 2011 Jan 13;117(2):530-41 - PubMed
  24. Front Immunol. 2017 Mar 07;8:201 - PubMed
  25. Virology. 2004 Aug 15;326(1):20-8 - PubMed
  26. Vaccine. 2000 Jul 1;18(26):3021-30 - PubMed
  27. Hum Vaccin Immunother. 2018 Jun 3;14(6):1483-1488 - PubMed
  28. Sci Rep. 2016 Jun 21;6:27251 - PubMed
  29. Vaccine. 2004 Sep 9;22(27-28):3789-96 - PubMed
  30. PLoS One. 2016 Mar 18;11(3):e0151761 - PubMed
  31. Mol Immunol. 2014 Dec;62(2):296-304 - PubMed
  32. J Immunol. 2013 Sep 1;191(5):2426-36 - PubMed
  33. Vaccine. 2001 Apr 6;19(20-22):2819-24 - PubMed
  34. Immunogenetics. 1995;41(6):366-74 - PubMed
  35. J Transl Med. 2016 Jun 14;14(1):175 - PubMed
  36. Immunology. 2001 Sep;104(1):75-9 - PubMed
  37. Hum Immunol. 1997 Nov;58(1):42-51 - PubMed
  38. Clin Exp Immunol. 2003 Mar;131(3):451-6 - PubMed
  39. J Immunol. 2012 Oct 15;189(8):3925-35 - PubMed
  40. Vaccine. 2008 Nov 18;26(49):6266-73 - PubMed
  41. Commun Dis Public Health. 2003 Jun;6(2):106-12 - PubMed
  42. Mol Med Rep. 2017 Jun;15(6):4338-4345 - PubMed
  43. Clin Exp Nephrol. 2018 Feb;22(1):151-158 - PubMed
  44. Hum Vaccin Immunother. 2017 May 4;13(5):1014-1017 - PubMed
  45. Cell Mol Immunol. 2013 Mar;10(2):122-32 - PubMed
  46. World J Gastroenterol. 2014 Aug 14;20(30):10383-94 - PubMed
  47. Vaccine. 1992;10(6):379-82 - PubMed
  48. Annu Rev Immunol. 1989;7:145-73 - PubMed
  49. Vaccine. 1999 Jan 28;17(4):330-9 - PubMed
  50. Epidemiol Rev. 2006;28:112-25 - PubMed
  51. J Hepatol. 2001 Jan;34(1):123-7 - PubMed
  52. Vaccine. 2008 Nov 5;26(47):5967-72 - PubMed
  53. J Inflamm Res. 2021 Jan 12;14:75-84 - PubMed
  54. Allergy. 2021 Sep;76(9):2699-2715 - PubMed
  55. J Infect Dis. 2008 Aug 1;198(3):299-304 - PubMed
  56. J Allergy Clin Immunol. 2013 Apr;131(4):1204-12 - PubMed
  57. Infect Genet Evol. 2021 Apr;89:104753 - PubMed
  58. Microbiol Immunol. 2018 Aug;62(8):485-496 - PubMed
  59. Front Immunol. 2018 Jan 19;8:1951 - PubMed

Publication Types